These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3980647)

  • 1. Liquid chromatographic assay of isoxicam in human plasma and urine.
    Bury RW
    J Chromatogr; 1985 Jan; 337(1):156-9. PubMed ID: 3980647
    [No Abstract]   [Full Text] [Related]  

  • 2. [Isoxicam: physicochemical characteristics and the quantitative determination by HPLC].
    Marini D; Pollino G
    Boll Chim Farm; 1984 Mar; 123(3):124-32. PubMed ID: 6743393
    [No Abstract]   [Full Text] [Related]  

  • 3. High-performance liquid chromatographic analysis of isoxicam in human plasma and urine.
    Daftsios AC; Johnson EL; Keeley FJ; Gryczko C; Rawski V
    J Chromatogr; 1984 Jan; 305(1):145-51. PubMed ID: 6707138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and synovial fluid concentrations of isoxicam in meniscectomized patients.
    Ballerini R; Casini A; Chinol M; Mannucci C; Melani F; Ungar F
    Drugs Exp Clin Res; 1985; 11(8):517-21. PubMed ID: 3841790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance thin-layer chromatographic assay for the routine determination of piroxicam in plasma, urine and tissue.
    Riedel KD; Laufen H
    J Chromatogr; 1983 Aug; 276(1):243-8. PubMed ID: 6672021
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interaction of isoxicam and digoxin].
    Zöller B; Engel HJ; Faust-Tinnefeldt G; Gilfrich HJ; Zimmer M
    Z Rheumatol; 1984; 43(4):182-4. PubMed ID: 6495892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid chromatographic determination of piroxicam in serum.
    Fraser AD; Woodbury JF
    Ther Drug Monit; 1983 Jun; 5(2):239-42. PubMed ID: 6879650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid method for the determination of either piroxicam or tenoxicam in plasma using high-performance liquid chromatography.
    Dixon JS; Lowe JR; Galloway DB
    J Chromatogr; 1984 Oct; 310(2):455-9. PubMed ID: 6511864
    [No Abstract]   [Full Text] [Related]  

  • 9. Factors affecting the kinetics of two benzothiazine non-steroidal anti-inflammatory medicines, piroxicam and isoxicam.
    Edwards IR; Ferry DG; Campbell AJ
    Eur J Clin Pharmacol; 1985; 28(6):689-92. PubMed ID: 4065194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of administration of propranolol on the pharmacokinetics of isoxicam.
    Caillé G; Larivière L; Lacasse Y; Vézina M; Besner JG
    Biopharm Drug Dispos; 1986; 7(1):63-9. PubMed ID: 3955200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Onset of effect of isoxicam and piroxicam. A double-blind parallel study].
    Bara S; Wagenhäuser FJ
    Fortschr Med; 1985 Jan; 103(4):73-6. PubMed ID: 3972324
    [No Abstract]   [Full Text] [Related]  

  • 12. Determination of Ro12-0068, a new anti-inflammatory and analgesic compound, in plasma by means of high-performance liquid chromatography.
    Pickup ME; Lowe JR; Galloway DB
    J Chromatogr; 1981 Oct; 225(2):493-7. PubMed ID: 7298785
    [No Abstract]   [Full Text] [Related]  

  • 13. Simultaneous determination of piroxicam, meloxicam and tenoxicam in human plasma by liquid chromatography with tandem mass spectrometry.
    Ji HY; Lee HW; Kim YH; Jeong DW; Lee HS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 826(1-2):214-9. PubMed ID: 16169293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of tenoxicam in human plasma by high-performance liquid chromatography.
    Heizmann P; Körner J; Zinapold K
    J Chromatogr; 1986 Jan; 374(1):95-102. PubMed ID: 3485110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of leukocyte peroxidases in the metabolism of tenoxicam.
    Ichihara S; Tomisawa H; Fukazawa H; Tateishi M
    Biochem Pharmacol; 1985 Apr; 34(8):1337-8. PubMed ID: 2986643
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic disposition of isoxicam in man, monkey, dog, and rat.
    Borondy PE; Michniewicz BM
    Drug Metab Dispos; 1984; 12(4):444-51. PubMed ID: 6148211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of impairment of renal function on the accumulation and disposition of isoxicam.
    Bury RW; Whitworth JA; Saines D; Kincaid-Smith P; Moulds RF
    Eur J Clin Pharmacol; 1985; 28(5):585-8. PubMed ID: 4043201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis induced by isoxicam.
    Ollagnon HO; Perpoint B; Decousus H; Ollagnier M; Queneau P
    Hepatogastroenterology; 1986 Jun; 33(3):109. PubMed ID: 2943659
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction of isoxicam with acetylsalicylic acid.
    Esquivel M; Cussenot F; Ogilvie RI; East DS; Shaw DH
    Br J Clin Pharmacol; 1984 Oct; 18(4):567-71. PubMed ID: 6487496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal blood loss during isoxicam and piroxicam administration for 28 days.
    Hooper JW; Anslow JA; Martin WS; Araujo P; Darke A
    Clin Pharmacol Ther; 1985 Nov; 38(5):533-7. PubMed ID: 3876907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.